# Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

> **NCT05351164** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Michigan** · enrollment: 4 (actual)

## Conditions studied

- Lipomatosis, Multiple Symmetrical

## Interventions

- **DRUG:** Metreleptin

## Key facts

- **NCT ID:** NCT05351164
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2024-04-08
- **Final completion:** 2028-10
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05351164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05351164, "Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT05351164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*